Congress
Authorship
M Fabiani
;
CASTRO, ELIANA FLORENCIA
;
MC Soraires Santacruz
;
LM Finkielsztein
;
LV Cavallaro
Date
2015
Publishing House and Editing Place
International Society for Antiviral Research
Summary
Information provided by the agent in
SIGEVA
New thiosemicarbazones derived from -indanones with antiviral activity againstbovine viral diarrhea virus.M. Fabiani1, E.F. Castro1, M.C. Soraires Santacruz2, L.M. Finkielsztein2, L.V. Cavallaro1.1Virología, Facultad de Farmacia y Bioquímica, UBA, Buenos Aires, Argentina; 2Química Medicinal, Facultad de Farmacia y Bioquímica, UBA, Buenos Aires, ArgentinaBovine viral diarrhea virus (BVDV) is the prototype Pestivirus. BVDV infection is distributed worldwide and ca...
New thiosemicarbazones derived from -indanones with antiviral activity againstbovine viral diarrhea virus.M. Fabiani1, E.F. Castro1, M.C. Soraires Santacruz2, L.M. Finkielsztein2, L.V. Cavallaro1.1Virología, Facultad de Farmacia y Bioquímica, UBA, Buenos Aires, Argentina; 2Química Medicinal, Facultad de Farmacia y Bioquímica, UBA, Buenos Aires, ArgentinaBovine viral diarrhea virus (BVDV) is the prototype Pestivirus. BVDV infection is distributed worldwide and causes serious problems for the livestock industry. The thiosemicarbazone (TSC) of 5,6-dimethoxy-1-indanone (lead compound) is a potent nonnucleoside polymerase inhibitor of BVDV. In order to find compounds with an improved anti-BVDV activity, a series of thirteen novel TSCs was synthesized. The aim of this work was to evaluate their antiviral activity in vitro against BVDV and to preliminarily analyze their structure activity relationship. The most active compounds were also evaluated against BVDV mutants resistant to the lead compound (BVDV-TSCr). From the N4-substituted TSCs with phenyl groups (1-9), only derivatives 4-9 were active, suggesting that the 5,6-dimethoxy substitution would improve the anti-BVDV activity. It should be noted that the nature of the substituent at the R3 position has an important effect: compounds with electron-withdrawing substituents (7 and 8) were the most active. Derivative 8 (R3=NO2) resulted to be almost six times more active than the lead compound (EC50= 0.7±0.3 and 3.8±0.4 μM, respectively). Among the TSCs 10-13, only compound 11 exerted an activity similar to that of the lead compound, suggesting that the NO2 group at the R3 position would enhance the antiviral activity in the absence of the 5,6-dimethoxy substitution. Finally, BVDV-TSCr were also resistant to compound 8 but, interestingly, they were slightly inhibited by compound 11. Further experiments and docking studies of these compounds should be held to determine the molecular interactions with the viral polymerase.
Show more
Show less
Key Words
BVDVTHIOSEMICARBAZONESANTIVIRAL